<code id='9756390C0B'></code><style id='9756390C0B'></style>
    • <acronym id='9756390C0B'></acronym>
      <center id='9756390C0B'><center id='9756390C0B'><tfoot id='9756390C0B'></tfoot></center><abbr id='9756390C0B'><dir id='9756390C0B'><tfoot id='9756390C0B'></tfoot><noframes id='9756390C0B'>

    • <optgroup id='9756390C0B'><strike id='9756390C0B'><sup id='9756390C0B'></sup></strike><code id='9756390C0B'></code></optgroup>
        1. <b id='9756390C0B'><label id='9756390C0B'><select id='9756390C0B'><dt id='9756390C0B'><span id='9756390C0B'></span></dt></select></label></b><u id='9756390C0B'></u>
          <i id='9756390C0B'><strike id='9756390C0B'><tt id='9756390C0B'><pre id='9756390C0B'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:63744

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. 

          How do we ensure the population in a study best reflects the people who will get a medicine in the real world?

          advertisement

          STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.

          Featured speakers:

          • LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
          • Ramita Tandon, chief clinical trials officer, Walgreens
          • Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
          • Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
          • Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)

          Sponsored By

          OneStudyTeam

           

          explore

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          SEC charges former device maker CEO with $41 million fraud
          SEC charges former device maker CEO with $41 million fraud

          From2017to2020,Stimwaveimplantednearly8,000patientswithnervestimulatorscontainingdummypiecesofplasti

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Treeline, Josh Bilenker's next biotech, is cloaked in mystery

          APPhoto/TedS.WarrenJoshBilenker’slastcompany,LoxoOncology,waspurchasedbyEliLillyfor$8billion.Nosurpr